Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 11 recruiting now full pipeline small index

Hydrocephalus: full-pipeline trial registry

11 of 18 indexed Hydrocephalus trials are currently recruiting.

Corpus placement: #953 of 28,707 conditions by registered trial count.

18 US clinical trials · 11 currently recruiting · #953 of 28,707 conditions by registered trial count

Hydrocephalus: 18 US clinical trials tracked, 11 recruiting.

Hydrocephalus is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Rhaeos, running 6 of these trials.

Enrollment posture brief

Registry condition hydrocephalus

OPEN 11 | RECR 61% | LATE 1 | EARLY 1 | RANK #953 | SPON 6

Nearest open-share peer: Breast Cancer Metastatic (61% recruiting · 18 trials)

Hydrocephalus (this)61%Arrhythmias, Cardiac27.8%Androgenetic Alopecia16.7%Anemia, Sickle Cell16.7%Acquired Immunodeficiency Sy5.6%
Open-enrollment share among volume-matched conditions near Hydrocephalus

Hydrocephalus lists 11 open slots (61% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hydrocephalus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hydrocephalus is recruiting above its size-band peers.

    11 of 18 indexed trials (61.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hydrocephalus research.

    Rhaeos accounts for 6 of 18 trials (33.3%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hydrocephalus enrolment sits around 84 participants.

    Median target enrolment is 84 among the 18 trials that report a genuine target (sentinel values excluded). 10 of those (55.6%) plan for fewer than 100 participants.

  4. Hydrocephalus splits between interventional and observational designs.

    11 interventional and 7 observational studies make up this index (61.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Open and recent trials

18 total, page 1 of 1

RECRUITING 581 participants

CoMind Early Feasibility Study

CoMind Technologies Limited

NCT06368648

RECRUITING Phase 3 176 participants

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

University of Utah

NCT04177914

RECRUITING 145 participants

Formative Usability Assessment of Wireless Thermal Anisotropy Devices

Rhaeos

NCT06040697

RECRUITING NA 130 participants

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device

Rhaeos

NCT06086561

RECRUITING Phase 1 84 participants

Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?

Montefiore Medical Center

NCT05001750

RECRUITING 70 participants

NIRS Monitoring in Premature Infants

Boston Children's Hospital

NCT02601339

RECRUITING NA 55 participants

Flow Detection in Open and Closed Shunt Valve Periods

Rhaeos

NCT07478926

RECRUITING NA 50 participants

MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics

Mayo Clinic

NCT04099823

RECRUITING NA 29 participants

Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device

Rhaeos

NCT06996600

RECRUITING NA 24 participants

EVD Drainage Data and Intracranial Pressure (ICP) Measurements

Baylor College of Medicine

NCT05546996

RECRUITING NA 24 participants

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Rutgers, The State University of New Jersey

NCT06797219

ACTIVE NOT RECRUITING 400 participants

Improving Infant Hydrocephalus Outcomes in Uganda

Boston Children's Hospital

NCT03650101

ACTIVE NOT RECRUITING NA 100 participants

Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging

University of Pennsylvania

NCT04436068

ACTIVE NOT RECRUITING NA 50 participants

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

CereVasc

NCT05232838

ACTIVE NOT RECRUITING NA 35 participants

Magnetic Resonance Elastography in Hydrocephalus

Dartmouth-Hitchcock Medical Center

NCT02230124

COMPLETED 141 participants

Assessment of CSF Shunt Flow With Thermal Measurements B

Rhaeos

NCT05432986

COMPLETED 120 participants

Establishing the Physiology of Syringomyelia

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00001327

COMPLETED 52 participants

Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device

Rhaeos

NCT06524492

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Hydrocephalus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Thermal Anisotropy Measurement Device Device
2 trials
FlowSense Device
2 trials
ETV/CPC Procedure
2 trials
Hyperfine MRI scan Device
1 trials
MRE Device
1 trials
eShunt Implant Device
1 trials
Thermal Anisotropy Device
1 trials
MR brain Diagnostic test
1 trials

US sites by state

Facility locations filed on Hydrocephalus trials. A trial with sites in several states counts in each.

Illinois 6 trials
Florida 5 trials
Pennsylvania 4 trials
New York 4 trials
Virginia 3 trials
Ohio 3 trials
Missouri 3 trials
California 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hydrocephalus page

18 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 11 Hydrocephalus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Rhaeos sponsors the most Hydrocephalus trials on record, review their full trial history before evaluating a specific study. See Rhaeos's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hydrocephalus condition card totals 18 registered trials; most-linked intervention Thermal Anisotropy Measurement Device; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.